CN108607043A - A kind of medicament for treating postpartum haemorrhage - Google Patents

A kind of medicament for treating postpartum haemorrhage Download PDF

Info

Publication number
CN108607043A
CN108607043A CN201611126539.7A CN201611126539A CN108607043A CN 108607043 A CN108607043 A CN 108607043A CN 201611126539 A CN201611126539 A CN 201611126539A CN 108607043 A CN108607043 A CN 108607043A
Authority
CN
China
Prior art keywords
parts
medicament
postpartum haemorrhage
herb
fern
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611126539.7A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Ximalaya Health Technology Co Ltd
Original Assignee
Tianjin Ximalaya Health Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Ximalaya Health Technology Co Ltd filed Critical Tianjin Ximalaya Health Technology Co Ltd
Priority to CN201611126539.7A priority Critical patent/CN108607043A/en
Publication of CN108607043A publication Critical patent/CN108607043A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/27Asclepiadaceae (Milkweed family), e.g. hoya
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/85Verbenaceae (Verbena family)
    • A61K36/855Clerodendrum, e.g. glorybower
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of medicaments for treating postpartum haemorrhage, it is made of the substance of following weight parts:80 parts of pale reddish brown amplexicaul swallowwort herb, 70 parts of adder's-fern, 60 parts of meter Tuan Hua, 65 parts of sowthistle, 60 parts of blowpipe, 50 parts of splended bredia herb, 55 parts of Canton love-pea vine, 50 parts of Cymbidium hookerianum, oil head careless 45 parts and 30 parts of Flos clerodendri japonici.Raw material of the present invention is easy to get, curative for effect, tests prove that high efficiency, at low cost.

Description

A kind of medicament for treating postpartum haemorrhage
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for treating postpartum haemorrhage.
Background technology
Postpartum haemorrhage refers to bleeding profusely of being difficult in postpartum stop.This is a kind of very serious but less common concurrent Disease.If processing in time would not critical life.Uterus excessively relaxes or since long-term beaten childbirth fails to tighten, Wound is excessive is likely to bleed for production.Metreurysma it is excessive may due to multiparity, fetus individual is big, hydramnion, Puerpera is in poor health such as anaemia, caused by frightened or over fatigue.Placenta deformity, can also prevent uterus symmetric shrinkage.Face at present Bed is generally prevented and is controlled using oxytocin, though effect is preferable, due to the necessary drug administration by injection of oxytocin, and individual is sensitive Sex differernce is larger, therefore there are inconveniences when actual therapeutic is applied.
Invention content
The object of the present invention is to provide a kind of medicaments for treating postpartum haemorrhage.
In order to achieve the object of the present invention, the present invention provides a kind of medicament for treating postpartum haemorrhage, it is by following weight The substance of part is made:It is 80 parts of pale reddish brown amplexicaul swallowwort herb, 70 parts of adder's-fern, 60 parts of meter Tuan Hua, 65 parts of sowthistle, 60 parts of blowpipe, beautiful 50 parts of Bredia fordii, 55 parts of Canton love-pea vine, 50 parts of Cymbidium hookerianum, oil head careless 45 parts and 30 parts of Flos clerodendri japonici.
Preferably, tablet, dispersible tablet, capsule or powder can be made in the medicament.
The present invention also provides purposes of the composition in the medicament for preparing treatment postpartum haemorrhage, the medicament foot is by following heavy The substance of amount part is made:80 parts of pale reddish brown amplexicaul swallowwort herb, 70 parts of adder's-fern, 60 parts of meter Tuan Hua, 65 parts of sowthistle, 60 parts of blowpipe, show 50 parts of beautiful Bredia fordii, 55 parts of Canton love-pea vine, 50 parts of Cymbidium hookerianum, oil head careless 45 parts and 30 parts of Flos clerodendri japonici.
In the present compositions, pale reddish brown amplexicaul swallowwort herb, adder's-fern are monarch drug in a prescription, meter Tuan Hua, sowthistle, blowpipe, beautiful Bredia fordii is ministerial drug, and Canton love-pea vine, Cymbidium hookerianum, oil head grass are adjutant, and Flos clerodendri japonici is to make medicine.
Pale reddish brown amplexicaul swallowwort herb
Original plants color tricky Cynanchum amplexicaule (Sieb.et Zucc.) Hemsl.var.castaneum Makino
Adder's-fern
Former plant Polypodium vulgare L.
Raw material of the present invention is easy to get, curative for effect, tests prove that high efficiency, at low cost.
Specific implementation mode
The following describes the present invention further through the description of specific embodiments, but this is not the limit to the present invention System, those skilled in the art's basic thought according to the present invention can make various modifications or improvements, but without departing from this The basic thought of invention, is all within the scope of the present invention.
The preparation of embodiment powder of the present invention
Take 80 grams of pale reddish brown amplexicaul swallowwort herb, 70 grams of adder's-fern, 60 grams of meter Tuan Hua, 65 grams of sowthistle, 60 grams of blowpipe, beautiful wild sea 50 grams of Chinese bush cherry, 55 grams of Canton love-pea vine, 50 grams of Cymbidium hookerianum, Shantou careless 45 grams and 30 grams of Flos clerodendri japonici, crush, sieve with 100 mesh sieve, sugarcane is then added 550 grams of sugar, mixing is fitted into 100 bags to obtain the final product.
Experimental example
Diagnostic criteria:
The diagnostic criteria of postpartum haemorrhage:Blood loss is more than 500 milliliters in 24 hours after delivery of baby.
The measurement method of postpartum haemorrhage:All cases use volumetric method and weight method.Vaginal delivery:Work as delivery of baby, sheep Flow is most, is encased inside under puerpera's stern connects blood device with milliliter scale at once, and the blood connect in blood device is then poured into measuring cup standard Really metering;Weight method is that dressing, the disinfecting towel before childbirth used in puerpera are all weighed, dressing that postpartum is soaked by blood, disinfection Towel, disposable waterproof sterilizing paper washer are weighed, and are subtracted just weight, the criterion calculation that 1ml blood is equivalent to by proportion 1.05g and are lost blood Amount.Cesarean section delivery:After cutting maternal uterine wall, first amniotic fluid is exhausted, then to connect blood device collection blood, the computational methods of amount of bleeding are same In vaginal delivery.
The patient 80 for meeting above-mentioned diagnostic criteria is chosen, the age is 26 years old minimum, 35 years old maximum, average age 29.5 years old.
It is treated using powder obtained in embodiment, wherein two times a day, one bag oral every time, 5 days are 1 treatment Journey.Other medicaments are deactivated during treatment.
Criterion of therapeutical effect
Improve situation as curative effect judging standard using hemorrhage items symptom:
It cures:Clinical symptoms and sign are all eliminated, and laboratory examination urinates pregnancy tests feminine gender, ultrasound diagnosis category normal-sub Palace attachment ultrasonogram, and efficacy consolidation;
It is effective:Clinical symptoms and sign make moderate progress;
In vain:Clinical symptoms, body are past not to be improved.
As a result by treatment, it is found that all patient clinical symptoms and sign are all eliminated, laboratory examination urinates pregnancy tests Feminine gender, ultrasound diagnosis category normal uterus attachment ultrasonogram, therefore whole the effect of meeting healing standards.And over the course for the treatment of Apparent adverse reaction is not found.

Claims (3)

1. a kind of medicament for treating postpartum haemorrhage, which is characterized in that it is made of the substance of following weight parts:Pale reddish brown amplexicaul swallowwort herb 80 parts, 70 parts of adder's-fern, 60 parts of meter Tuan Hua, 65 parts of sowthistle, 60 parts of blowpipe, 50 parts of splended bredia herb, 55 parts of Canton love-pea vine, tiger Head is 50 parts blue, oil head careless 45 parts and 30 parts of Flos clerodendri japonici.
2. it is according to claim 1 treatment postpartum haemorrhage medicament, which is characterized in that the medicament can be made tablet, Dispersible tablet, capsule or powder.
3. purposes of the composition in the medicament for preparing treatment postpartum haemorrhage, which is characterized in that the medicament is by following weight The substance of part is made:It is 80 parts of pale reddish brown amplexicaul swallowwort herb, 70 parts of adder's-fern, 60 parts of meter Tuan Hua, 65 parts of sowthistle, 60 parts of blowpipe, beautiful 50 parts of Bredia fordii, 55 parts of Canton love-pea vine, 50 parts of Cymbidium hookerianum, oil head careless 45 parts and 30 parts of Flos clerodendri japonici.
CN201611126539.7A 2016-12-09 2016-12-09 A kind of medicament for treating postpartum haemorrhage Pending CN108607043A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611126539.7A CN108607043A (en) 2016-12-09 2016-12-09 A kind of medicament for treating postpartum haemorrhage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611126539.7A CN108607043A (en) 2016-12-09 2016-12-09 A kind of medicament for treating postpartum haemorrhage

Publications (1)

Publication Number Publication Date
CN108607043A true CN108607043A (en) 2018-10-02

Family

ID=63657396

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611126539.7A Pending CN108607043A (en) 2016-12-09 2016-12-09 A kind of medicament for treating postpartum haemorrhage

Country Status (1)

Country Link
CN (1) CN108607043A (en)

Similar Documents

Publication Publication Date Title
CN104224923A (en) Tea tree essential oil antimicrobial gel for treating vaginal disease in gynecology
CN103349766B (en) Pharmaceutical composition for endless postpartum lochia
CN103316312B (en) A kind of tonification clearing heat in the pericardium mixture and preparation technology thereof
CN102764322A (en) Traditional Chinese medicine composite for curing sterility and irregular menstruation
CN102078565B (en) Traditional Chinese medicine prescription for treating ectopic pregnancy
CN108607043A (en) A kind of medicament for treating postpartum haemorrhage
CN108498705A (en) Vagina doubts glue bolt and preparation method thereof
CN101773627B (en) Chinese medicament for treating postpartum lochiorrhea
CN103550525B (en) Drug for treating pubertal dysfunctional uterine bleeding
CN1299716C (en) Detergent in use for department of gynecology
CN104224985B (en) A kind of Chinese medicine for treating postpartum lochiorrhea
CN102319330A (en) Traditional Chinese medicine cataplasma for treating hyperosteogeny and preparation method thereof
CN104800507B (en) Promote elderly parturient women's cesarean postoperate wound healing and reduces the Chinese medicine composition of complication
CN105920150A (en) Oral liquid for treating functional uterine bleeding and preparation method thereof
CN104758619A (en) Medicine for treating postpartum hemorrhage
CN101569697B (en) Chinese traditional medicine for treating postpartum retained afterbirth of female animals
CN107007652A (en) Purposes of the Kangfuxin Liquid Combined with Chinese Herbal in the medicine for preparing treatment infertility
US8894599B2 (en) Uterine stimulant sticks
CN101099856A (en) Health food with auxiliary protective function to gastric mucosa injure
CN1935157A (en) Medical stone emulsifiable paste for treating skin disease and its preparing method
CN105106431A (en) Traditional Chinese medicine perfusion agent for treating cow ovarian quiescence and persistent corpus luteum infertility and preparation method thereof
Choudhary et al. Role of Sthanik Chikitsa in Stree Roga
CN103550372A (en) Medicament for medical abortion
CN104758626B (en) A kind of medicament for drug induced abortion
CN103330887B (en) Pharmaceutical composition for treatment of postpartum lochiorrhea

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20181002

WD01 Invention patent application deemed withdrawn after publication